Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Circulation|July 1, 1991
Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolismC F Reilly, T Fujita, J E Hutzelmann, et al.
Thrombosis and Haemostasis|December 28, 1990
Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatusR J Shebuski, D R Ramjit, G R Sitko, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dogR J Shebuski, J M Smith, B L Storer, et al.
Prostaglandins|December 1, 1979
Prostacyclin stimulation of dog arterial cyclic AMP levelsO V Miller, J W Aiken, D P Hemker, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dogR J Shebuski, T Fujita, J M Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergyG A Kopia, L J Kopaciewicz, E H Ohlstein, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivoC F Toombs, N R Norman, V E Groppi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilatJ C Hartman, G M Kurc, T G Hullinger, et al.
Thrombosis and Haemostasis|April 25, 1989
Demonstration of Ac-Arg-Gly-Asp-Ser-NH2 as an antiaggregatory agent in the dog by intracoronary administrationR J Shebuski, D E Berry, D B Bennett, et al.
Blood|April 1, 1990
Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activatorR J Shebuski, G R Sitko, D A Claremon, et al.
Pageof 6